SAN ANTONIO, Aug. 11, 2015 /PRNewswire/ -- Mission Pharmacal Company is pleased to announce that its President, Neill "Gobie" Walsdorf, Jr., has been named to PharmaVOICE magazine's prestigious annual list recognizing the 100 most inspiring people in the life sciences. Those chosen for this elite group are selected for their positive contributions as leaders who think differently, address the big challenges facing the industry, and lead teams through passionate inspiration.
Walsdorf was recognized for his passion and creativity in continuing Mission's legacy of fulfilling overlooked healthcare needs by forging distinctive, highly productive national and international partnerships. Through his vision and perseverance to bring unique solutions to customers, Mission has delivered a host of new product and sales service offerings to benefit patients, healthcare providers, and partner companies in recent years. In particular, Walsdorf focuses on new products that improve convenience for patients, making it more likely that they will follow treatment guidelines.
"Gobie Walsdorf's distinctive barrier-breaking partnership approach to bring innovative products to market that provide novel ways to improve convenience for patients is just one of the ways he is inspiring his employees, and the greater healthcare community," says Taren Grom, cofounder and editor, PharmaVOICE. "Mr. Walsdorf is also highly committed to giving back and has created a company culture that actively encourages volunteerism."
Recent product breakthroughs that Walsdorf and his Mission team have delivered to help patients with underserved healthcare needs include convenient dermatology solutions, an effervescent oral solution for treating osteoporosis, a protective oral spray to help relieve dry mouth, several kidney stone and urologic solutions, and an environmentally friendly zinc oxide spray that can be used at all ages to soothe, treat, and protect irritated skin, including in long-term care situations as an adult barrier spray.
Additionally, earlier this year Walsdorf expanded Mission's already broad, state-of-the-art manufacturing offerings with the acquisition of the assets of ProSolus Pharmaceuticals, LP, headquartered in Miami, FL. This gives Mission specialty expertise in the development and manufacturing of effective, convenient transdermal (through-the-skin) drug delivery products.
Walsdorf shows a strong commitment to helping others through his involvement and support of numerous charitable healthcare, research, and educational organizations, particularly those serving the needs of the youngest and oldest community members. For instance, Walsdorf spearheads Mission's hands-on participation and six-year national sponsorship supporting the annual March of Dimes March for Babies. He also serves on the advisory council of the Buck Institute for Research on Aging, the University of Texas College of Communications Advisory Board, and the University of Texas Development Board.
Established more than 10 years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life science industry.
Selected from thousands of nominations, the distinguished honorees are selected based on substantive accounts describing how they have inspired or motivated their colleagues, peers, and even competitors, have affected positive changes in their own organizations, as well as give back to their communities and other philanthropic causes.
To view Walsdorf's complete PharmaVOICE 100 profile, please visit the July/August 2015 online digital edition at pharmavoice.com.
To learn more about Mission Pharmacal Company and its high-quality healthcare products, please visit missionpharmacal.com.
SOURCE Mission Pharmacal Company